Physicians World/Thomson Healthcare (PW), a full-service medical communications company, announces its recent selection by Sepracor Inc., Marlborough, MA, as medical education and communications agency of record for the company's current product, XOPENEX® (levalbuterol HCl), and rapidly advancing, late-stage portfolio.
"Physicians World has a...history of creating scientifically sound and effective educational programs with the assistance of the most renowned academics and physician thought leaders in medicine," said Martin Cearnal, president of PW. "Sepracor is a research-based pharmaceutical company that selects for development compounds with the potential to offer improvements over existing therapies with respect to efficacy, side-effect profile, and improved dosage forms. With our combined expertise, we will be able to help physicians and allied health professionals increase their understanding of Sepracor's new, proprietary products to enhance the clinical care they provide their patients."
Sepracor has developed a portfolio of pharmaceutical candidates that are focused on the treatment of respiratory, urological and gastroenterological, and central nervous system disorders.
Physicians World/Thomson Healthcare is a full-service provider of medical education programs, publication planning, scientific symposia, and pharmacoeconomic research-aimed at accelerating awareness of new therapies among key physician constituencies.